SELECT MEDICAL HOLDINGS CORP

Last chapter of Select Medical Holdings’ merger: Scully Thomas sells remaining shares at $16.50, while insider sales and high sentiment signal a new era for investors.

Insider sales at Select Medical Holdings Corp. show modest liquidity yet steady ownership, indicating management confidence and potential long‑term upside in the post‑acute healthcare market.

Investor insight: Select Medical’s tax‑driven insider sale shows leadership remains invested amid a modest $16.50 merger premium, while earnings and dividend stability guide cautious optimism.

Insider buying surge by William Frist signals confidence in Select Medical’s growth and upcoming merger, offering investors a bullish outlook for 2026.